Teri Lawver

Janssen Pharmaceuticals, Global Vice President, Immunology, Global Commercial Strategy Leader

Appointed to this role in 2017, Teri has end-to-end responsibility for Janssen Immunology’s portfolio and pipeline. She has been a leader in transforming the Immunology strategy, accelerating growth and generating revenues over $13B annually through a period of significant market disruption.

Since joining Johnson & Johnson (J&J) in 2002, she has held leadership positions of increasing scope and consistently delivered above-market performance. Prior to joining J&J, Teri was an Associate Principal at McKinsey & Company and a leader in the firm’s healthcare practice. She began her career as a Derivatives Analyst at Bloomberg Financial Markets.

Teri has a track record of shaping innovative strategies, building diverse, high performing teams, and inspiring organizations to deliver sustainable growth and value creation. She has been recognized by NJ Biz as one of New Jersey’s Top 50 Women in Business, and featured in Thrive magazine.

Teri holds a Bachelor of Science degree, summa cum laude, from Georgetown University, and a Masters of Business Administration from Duke University.

Teri serves as Chairman of the Board of Directors for Episcopal Relief & Development, and on the Board of Trustees for the New Jersey Symphony Orchestra. She resides in NJ with her husband, two children, and giant rescue dog.

Articles by Teri Lawver

De-Bunking Five Common Myths of Mentorship

Janssen's Global VP of Immunology busts five common mentoring myths -- from seeking similar mentors to formalizing every relationship. See roles at Janssen.